NOVARTIND.NS
Price:
$674
Market Cap:
$19.63B
Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and Exelon brands; pain and inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic, and Sandimmun Neoral brands. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2020-10-07
Stock Exchange
NSE
Ticker
NOVARTIND.NS
According to Novartis India Limited’s latest financial reports and current stock price. The company's current PE Ratio is 21.75. This represents a change of 2.20% compared to the average of 21.28 of the last 4 quarters.
The mean historical PE Ratio of Novartis India Limited over the last ten years is -4.07. The current 21.75 PE Ratio has changed -53479.87% with respect to the historical average. Over the past ten years (40 quarters), NOVARTIND.NS's PE Ratio was at its highest in in the June 2019 quarter at 524.73. The PE Ratio was at its lowest in in the December 2020 quarter at -590.65.
Average
-4.07
Median
25.79
Minimum
-392.50
Maximum
123.03
Discovering the peaks and valleys of Novartis India Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 271.96%
Maximum Annual PE Ratio = 123.03
Minimum Annual Increase = -703.79%
Minimum Annual PE Ratio = -392.50
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 19.76 | -34.25% |
| 2024 | 30.06 | 123.72% |
| 2023 | 13.43 | -103.42% |
| 2022 | -392.50 | -703.79% |
| 2021 | 65.01 | -47.16% |
| 2020 | 123.03 | 271.96% |
| 2019 | 33.08 | 53.60% |
| 2018 | 21.53 | -39.19% |
| 2017 | 35.41 | 238.77% |
| 2016 | 10.45 | -54.00% |
The current PE Ratio of Novartis India Limited (NOVARTIND.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
21.08
5-year avg
-52.85
10-year avg
-4.07
Novartis India Limited’s PE Ratio is greater than Lincoln Pharmaceuticals Limited (17.53), less than TTK Healthcare Limited (31.26), greater than Bafna Pharmaceuticals Limited (21.39), greater than Ind-Swift Limited (0.30), greater than Ind-Swift Limited (0.30), greater than Vivimed Labs Ltd. (-1.85), greater than Parenteral Drugs (India) Ltd. (-0.11), greater than Ortin Laboratories Limited (-2.06), less than Albert David Limited (68.87), less than Max Healthcare Institute Limited (90.98),
| Company | PE Ratio | Market cap |
|---|---|---|
| 17.53 | $12.76B | |
| 31.26 | $19.65B | |
| 21.39 | $242.50M | |
| 0.30 | $853.64M | |
| 0.30 | $850.39M | |
| -1.85 | $410.42M | |
| -0.11 | $101.08M | |
| -2.06 | $165.31M | |
| 68.87 | $6.19B | |
| 90.98 | $9.22B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novartis India Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novartis India Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Novartis India Limited's PE Ratio?
How is the PE Ratio calculated for Novartis India Limited (NOVARTIND.NS)?
What is the highest PE Ratio for Novartis India Limited (NOVARTIND.NS)?
What is the 3-year average PE Ratio for Novartis India Limited (NOVARTIND.NS)?
What is the 5-year average PE Ratio for Novartis India Limited (NOVARTIND.NS)?
How does the current PE Ratio for Novartis India Limited (NOVARTIND.NS) compare to its historical average?